Research - Riverside, California, United States
Immogen Bio is using the power of the immune system to target brain tumors. Our patented technology. called CD4see, mobilizes CD4+ T cells to hunt down and destroy glioblastoma tumor cells. Immogen Bio is privately held preclincal stage company based in California.
reCAPTCHA
Gmail
Apache
Weebly
Google Apps
Google Analytics